Oncology Institute, Inc. (TOI) Stock Statistics & Valuation Metrics

Oncology Institute, Inc. has a market cap or net worth of $163.63M. The enterprise value is $96.96M.

Oncology Institute, Inc. has 75.75M shares outstanding. The number of shares has decreased by -2.65% in one year.

Oncology Institute, Inc.’s return on equity (ROE) is -18.02 and return on invested capital (ROIC) is -47.23%.

The current PE Ratio of Oncology Institute, Inc. is -358.61. Oncology Institute, Inc.’s PEG ratio is 3.59.

In the last 12 months, Oncology Institute, Inc. had revenue of $393.41M and earned -$61.05M in profits. Earnings per share was -$0.01.

In the last 12 months, operating cash flow was -$26.54M and capital expenditures -$3.79M, giving a free cash flow of -$30.33M billion.

Oncology Institute, Inc. pays an annual dividend of , resulting in a dividend yield of

Oncology Institute, Inc. upcoming earnings date is May 7, 2025, Before Open.

Oncology Institute, Inc. as a current ratio of 2.15, with Debt / Equity ratio of 8.36

In the past 12 months, Oncology Institute, Inc. has paid -$3.62M in taxes.

Oncology Institute, Inc. EV to EBITDA ratio is -455.36, with an EV/FCF ratio of -763.97.

Oncology Institute, Inc. has $49.67M in cash and marketable securities with $30.02M in debt, giving a net cash position of -$19.65M billion.

Gross margin is 100.00%, with operating margin of -15.28%, and net profit margin of -16.44%.

The average price target for Oncology Institute, Inc. is , which is 11.43% higher than the current price. The consensus rating is